Site Search
Search Results
It is Time to Reduce the Burden of Cancer on Hoosiers
... testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment. “ACS CAN also looks forward to continuing the ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...
Governor Signs Legislation that Provides Access to Precision Treatment for All Oklahomans
Today, Gov. Kevin Stitt signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. Senate Bill 513 will enable more patients to benefit from biomarker testing, ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we know it, for everyone. Join the fight by visiting www.fightcancer.org . 0 The new law is aimed at improving health outcomes for All Oklahomans Governor Signs Legislation that Provides Access to Precision Treatment for All Oklahomans ...
Legislation Introduced to Increase Pennsylvanians’ Access to Biomarker Testing, the Key to Precision Medicine
... following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week. A game-changing part of cancer care, biomarker testing opens the door to targeted therapy and personalized medicine which can improve patient survivorship and quality of life. ... likely to receive biomarker testing. The push to expand access to biomarker testing has drawn the support of medical professionals and public health groups representing patients across the disease spectrum; at present, over 20 organizations are working together with ACS CAN to pass Senate ... me time, money and emotional stress by ruling out unnecessary treatments. It is vital that all Pennsylvanians have access to the same cancer care I do. Our lawmakers must do what’s right and pass this bill.” If passed, Senate Bill 954 / House Bill 1754 would require ...
More Californians with Cancer, Other Chronic Diseases, Get Access to Game-Changing Testing
... the state budget on June 29, allowing for Medi-Cal implementation of Senate Bill 496. Starting July 1st, Medi-Cal and other state-regulated health insurance plans will cover comprehensive biomarker testing when supported by medical and scientific evidence. Testing for specific ... of Ontario who was diagnosed with stage-four lung cancer, access to biomarker testing was a game-changer. “Despite being on chemotherapy, my health was taking a turn for the worse. My family and I were preparing for my imminent death when I received the biomarker testing results that led ... I had undergone chemotherapy,” said Khanna. “This new law removes barriers to precision medicine and can potentially reduce overall health care costs by avoiding unnecessary hospitalizations and treatments. It will turn the promise of precision medicine into a reality for more ...
Biomarker Testing Bill Fails to Advance: Washington Falling Behind in Access to Precision Medicine
... by cancer together to call on the Washington Legislature to make cancer a policy priority. Beyond its game-changing contributions to cancer care, biomarker testing is important in the treatment of arthritis, other autoimmune conditions and rare diseases, with ongoing research happening ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...
Lawmakers Take Critical Step to Revolutionize Cancer Treatment in Georgia, State’s Second Leading Cause of Death
... biomarker testing – a routine step in accessing personalized medicine treatments that has become an increasingly important part of cancer care in recent years due to its significant impact in improving survivorship and quality of life. Progress in the fight against cancer has been ... great promise in ensuring the delivery of the right treatment at the right time,” shared Rep. Sharon Cooper, Chairman of the House Public Health Committee who sponsored the bill. “By aligning coverage of biomarker testing with the latest science, we can help achieve better health outcomes, improved quality of life and potentially reducing costs by allowing some Georgians to bypass costly and ineffective treatments, ...
Advocates Hold Cancer Action Day at Capitol, Urging Lawmakers to Expand Access to Biomarker Testing & Paid Medical Leave, Address Medical Debt
... Johnson, Co-Founder and Medical Co-Director of the Precision Medicine Initiative at the Sydney Kimmel Comprehensive Cancer Center at Jefferson Health, highlighted the importance of improving Pennsylvanians’ access to paid family and medical leave and alleviating their medical debt. “If we are able to improve patients’ access to the quality care they need without fear of impacting their employment, then we can begin to address the pervasive, financially toxic issue of medical debt,” ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer ...
Survivor Views: One in Ten Impacted by Recent Drug Shortages
... drug shortages at 22%. Among those who have been impacted by drug shortages in the past year, 57% say the shortage was related to their cancer care, including medications to treat cancer as well as its side effects and complications. Nearly a third of those experiencing drug shortages ... that they would otherwise have addressed in an office visit. While most of those telehealth visits (78%) took place during the Covid-19 Public Health Emergency (PHE), the number reporting telehealth visits conducted outside of the PHE climbed from 15% prior to the PHE to 40% who have ... to have telehealth visits since the end of the PHE in May 2023. Forty-two percent say they plan to continue using telehealth visits with health care providers about issues related to their cancer. Fifteen percent of those surveyed have seen a provider located in a different ...
State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments
Video with cancer survivor’s story here . Sacramento, Calif. – The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision ... that have been under-resourced, including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help ... California Legislative Director for ACS CAN. “Improving coverage for and access to biomarker testing across insurance types is key to reducing health inequities and improving cancer outcomes.” For more information on precision medicine, cancer biomarkers, current barriers to biomarker ...
Expand Access to Biomarker Testing in Vermont
... are working together to make sure more Vermont residents can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...
Type
Priority Issue
State
- New York (19) Apply New York filter
- Pennsylvania (15) Apply Pennsylvania filter
- New Jersey (10) Apply New Jersey filter
- California (8) Apply California filter
- Ohio (8) Apply Ohio filter
- Colorado (6) Apply Colorado filter
- Florida (5) Apply Florida filter
- Kentucky (5) Apply Kentucky filter
- Maine (5) Apply Maine filter
- Connecticut (4) Apply Connecticut filter
- Georgia (4) Apply Georgia filter
- Hawaii (4) Apply Hawaii filter
- Indiana (4) Apply Indiana filter
- Maryland (4) Apply Maryland filter
- North Carolina (4) Apply North Carolina filter
- Washington (3) Apply Washington filter
- West Virginia (3) Apply West Virginia filter
- Iowa (2) Apply Iowa filter
- Massachusetts (2) Apply Massachusetts filter
- Minnesota (2) Apply Minnesota filter
- Nevada (2) Apply Nevada filter
- New Hampshire (2) Apply New Hampshire filter
- Texas (2) Apply Texas filter
- Vermont (2) Apply Vermont filter
- Delaware (1) Apply Delaware filter
- Louisiana (1) Apply Louisiana filter
- Michigan (1) Apply Michigan filter
- New Mexico (1) Apply New Mexico filter
- Oklahoma (1) Apply Oklahoma filter
- Oregon (1) Apply Oregon filter
- Rhode Island (1) Apply Rhode Island filter
- Tennessee (1) Apply Tennessee filter